CXCL9 and macrophage activation syndrome: Additionally, a higher ratio of IL-18 to CXCL9 was observed in patients with MAS if compared to patients with familial or infection-associated HLH (>24 000 pg/mL, 83% sensitivity and 94% specificity) (79).